Cargando…
Profiling of inhibitory immune checkpoints in glioblastoma: Potential pathogenetic players
Glioblastoma (GBM) represents the most frequent glial tumor, with almost 3 new cases per 100,000 people per year. Despite treatment, the prognosis for GBM patients remains extremely poor, with a median survival of 14.6 months, and a 5-year survival less than 5%. It is generally believed that GBM cre...
Autores principales: | Lombardo, Salvo Danilo, Bramanti, Alessia, Ciurleo, Rosella, Basile, Maria Sofia, Pennisi, Manuela, Bella, Rita, Mangano, Katia, Bramanti, Placido, Nicoletti, Ferdinando, Fagone, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583708/ https://www.ncbi.nlm.nih.gov/pubmed/33123243 http://dx.doi.org/10.3892/ol.2020.12195 |
Ejemplares similares
-
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy
por: Lombardo, Salvo Danilo, et al.
Publicado: (2021) -
Discovering common pathogenetic processes between COVID-19 and diabetes mellitus by differential gene expression pattern analysis
por: Rahman, Md Rezanur, et al.
Publicado: (2021) -
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
por: Cavalli, Eugenio, et al.
Publicado: (2020) -
Cognitive Decline in Rheumatoid Arthritis: Insight into the Molecular Pathogenetic Mechanisms
por: Basile, Maria Sofia, et al.
Publicado: (2021) -
The Role of Macrophage Migration Inhibitory Factor in Alzheimer′s Disease: Conventionally Pathogenetic or Unconventionally Protective?
por: Petralia, Maria Cristina, et al.
Publicado: (2020)